The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia (GIM)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) images interpretation in Gastric Intestinal Metaplasia (GIM)
Objective:
The aim of this study is to evaluate the learning curve of pCLE images interpretation in GIM.
Research design:
Blinded review of pCLE images for the diagnosis of GIM
Sample size:
Five beginner endoscopists will be assigned in this study to read approximately 80 videoclips
Data analysis:
ROC curve is analyzed by SPSS version 16.
Expected Benefit and Clinical Application Information on the learning curve for GIM interpretation from pCLE images in order to develop early gastric cancer detection
| Condition |
|---|
|
Gastric Intestinal Metaplasia |
| Study Type: | Observational |
| Study Design: | Time Perspective: Cross-Sectional |
| Official Title: | The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia(GIM) |
- The change of accuracy of pCLE images interpretation in GIM after each examination [ Time Frame: Baseline and every 2 weeks for 4 sessions ] [ Designated as safety issue: Yes ]Percentage of accuracy changing in each examination
| Estimated Enrollment: | 5 |
| Study Start Date: | September 2011 |
| Estimated Study Completion Date: | April 2012 |
| Estimated Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| pCLE images |
Detailed Description:
Background and Rationale:
Gastric cancer remains the second leading cause of cancer related death in the world. The incidence and mortality rate is predominant in East Asia[1]. Usually, gastric cancer is asymptomatic in early stage; therefore, most patients are in the advanced stage and incurable at diagnosis. The pathogenesis of intestinal type gastric cancer is sequential and multistep pathway. Gastric intestinal metaplasia (GIM) is the precancerous lesion for intestinal type gastric cancer[2]. The strategies which can detect precancerous and/or early cancerous transformation are very beneficial because only early gastric cancer can potentially be cured by endoscopic treatment. Probe-based confocal laser endomicroscope or pCLE is useful for GIM detection with 94% in sensitivity[3]. However, this perfect sensitivity in pCLE interpretation is provided in only expertise. We still do not know how to be an expert in GIM interpretation. No study about learning curve in GIM interpretation by pCLE published
Observation and Measurement:
Collect the accuracy in GIM interpretation from pCLE reported in ROC curve
Methodology:
- Six inexperienced pCLE readers were recruited.
- All inexperienced pCLE readers must attend the learning session.
- Self-review from CD is recommended for all inexperienced pCLE readers
- Two-week interval for examination in GIM interpretation from 20 new histology-proved pCLE images (GIM and normal mucosa) for 5 sessions are on schedule after training session.
- All Inexperienced pCLE readers need to review the training CD at least a day before each examination.
- The accuracy rate in each examination will be recorded individually for each inexperienced pCLE reader.
- ROC curve is reported for learning curve in GIM interpretation from pCLE images.
Data collection:
All data will be processed and recorded by one physician.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
5 beginner endoscopists who never had the experience in pCLE
Inclusion Criteria:
- First year fellow of gastroenterologist who never have the experienced in pCLE interpretation.
Contacts and Locations| Contact: Rapat Pittayanon, MD | 66813132112 | Rapat125@gmail.com |
| Contact: Nuttaphat Namjud, M.Sc. | 66894971957 | ampere_nut@hotmail.com |
| Thailand | |
| Rapat Pittayanon | Recruiting |
| Bangkok, Thailand, 10330 | |
| Contact: Rapat Pittayanon, MD 66813132112 rapat125@gmail.com | |
| Contact: Nuttapaht Namjud, M.Sc 66894971957 ampere_nut@hotmail.com | |
| Sub-Investigator: Rungsun Rerknimitr, Professor | |
| Principal Investigator: Rapat Pittayanon, MD | |
| Study Director: | Rungsun Rerknimitr, Professor | King Chulalongkorn Memorial Hospital |
| Principal Investigator: | Rapat Pittayanon, MD | King Chulalongkron Memorial Hospital |
More Information
Additional Information:
No publications provided
| Responsible Party: | Rapat Pittayanon, MD, Principle investigator, King Chulalongkorn Memorial Hospital |
| ClinicalTrials.gov Identifier: | NCT01491724 History of Changes |
| Other Study ID Numbers: | RP001 |
| Study First Received: | December 5, 2011 |
| Last Updated: | December 14, 2011 |
| Health Authority: | Thailand: Ethical Committee |
Additional relevant MeSH terms:
|
Metaplasia Gastritis, Atrophic Pathologic Processes Gastritis |
Gastroenteritis Gastrointestinal Diseases Digestive System Diseases Stomach Diseases |
ClinicalTrials.gov processed this record on May 21, 2013